REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Megalabs Colombia Sas (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Megalabs Colombia Sas Profile Updated: March 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Importar, exportar, comprar, vender, ptoducir, transformar, envasar, empacar, procesar, almacenar, acondicionar, distribuir, promocionar, comercializar toda clase de productos farmaceuticos, quimicos-.

Headquarters
Carrera 98 25 G 10 Bodega 13 - 14 Centro Empresarial El Dorado
Bogota D.C.; Bogota D.C; Postal Code: 0703

Contact Details: Purchase the Megalabs Colombia Sas report to view the information.

Basic Information
Total Employees:
Purchase the Megalabs Colombia Sas report to view the information.
Outstanding Shares:
Purchase the Megalabs Colombia Sas report to view the information.
Registered Capital:
Purchase the Megalabs Colombia Sas report to view the information.
Incorporation Date:
June 24, 1991
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Ownership Details
Purchase this report to view the information.
Subsidiaries
Galenica Droguerias S.A.S.
Company Performance
Financial values in the chart are available after Megalabs Colombia Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
11.21%▲
Total operating revenue
9.86%▲
Operating profit (EBIT)
-7.37%▼
EBITDA
-7.04%▼
Net Profit (Loss) for the Period
-10.86%▼
Total assets
12.03%▲
Total equity
22.1%▲
Operating Profit Margin (ROS)
-3.55%▼
Net Profit Margin
-2.91%▼
Return on Equity (ROE)
-6.69%▼
Quick Ratio
0.34%▲
Cash Ratio
-0.05%▼

Similar companies

Droguerias y Farmacias Cruz Verde S.A.S
 
Tecnoquimicas S.A.
Bayer S A
 
Novartis de Colombia S A
Procaps S.A.
 
Merck Sharp & Dohme Colombia S.A.S
Novamed S.A.S.
 
Laboratorios Siegfried S.A.S
Merck S A
 
Laboratorio Profesional Farmaceutico S.A.S. Pero Podra Igualmente Emplear La Expresion Abreviada: Laboratorios Laproff S.A.S.
Humax Pharmaceutical S.A.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo